Germany, Spain, and Italy lead in registered rheumatoid arthritis stem-cell trials, with university rheumatology departments collaborating with cell-therapy centres. Poland and Czech Republic also conduct active research with lower cost structures. Austria has several registered trials within university hospitals. France maintains selected protocols at teaching hospitals. United States capacity is fragmented; the NIH database lists fewer US-based RA-specific MSC trials than European alternatives. Selection should prioritise published safety data, trial registration, and institutional credentials in rheumatology, not marketing claims.
Rheumatoid arthritis stem-cell treatment costs typically range €3,500–6,500 per infusion, depending on cell source, expansion scale, and delivery route. Intra-articular injection into one or few joints is less expensive than systemic administration. Placental MSCs are favoured for cost-efficiency and immunogenicity profile relative to other sources. Disease duration and number of affected joints may influence whether monotherapy or repeat infusions are proposed. European programmes in Italy, Germany, and Spain generally charge at the lower end; private boutique clinics may exceed €7,000. Some trial sites offer treatments at reduced cost to enrolled participants.
Съм ли кандидат? → · Rheumatoid Arthritis: full overview → · Цена Ревматоидна артрит → · Cost →
Медицински преглед от редакционния екип на StemCellAtlas с Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) на партньорската клиника Stem Plus (София), спрямо ISSCR, FDA и EMA указания. Educational information, not medical advice; figures indicative.
GMP-сертифицирана регенеративна медицина в сърцето на ЕС — от 3 000–8 000 €, част от цените в САЩ или Германия. Персонализирани протоколи за пациенти от над 50 държави.
Безплатна медицинска оценка